文献速递肾移植

美国肾移植中心对COVID-19康复活体肾供者接受实践的全国调查

A National Survey of Practice Patterns for Accepting Living Kidney Donors With Prior COVID-19.
PubMed 文献 · Kidney Int Rep · 2021-05-15

该研究于2020年9月至11月调查美国115家移植中心174名受访者,了解对COVID-19康复活体肾供者的接受实践。结果显示各中心实践差异大,48.6%中心曾接咨询,27.8%已批准42名供者捐赠;最常见排除原因为COVID-19相关急性肾损伤(59.8%)。

要点

  • 各中心对COVID-19康复活体肾供者的接受标准差异显著。
  • 多数受访者倾向感染后等待至少1个月再手术,50.8%倾向等待超过3个月。
  • 最常见排除原因是COVID-19相关急性肾损伤(59.8%),即使已恢复。

核心结论

  • 对COVID-19康复活体肾供者的接受实践差异很大,需进一步研究和共识制定以指导安全实践。
  • 建议对此类供者进行长期密切随访。

研究设计与样本

  • 2020年9月3日至11月3日对美国移植项目进行问卷调查,分析中心和参与者层面应答。
  • 共115个中心174名受访者,代表59%的美国活体肾供者项目及2019年72.4%、2020年72.5%的活体肾供者量。

主要发现

  • 48.6%应答中心曾收到此类供者咨询,44.3%正在评估,98名供者处于评估阶段。
  • 27.8%中心已批准42名此类供者继续捐赠。
  • 50.8%参与者倾向等待>3个月,91%会等待至少1个月从感染 onset 到活体肾供手术。
  • 最常见排除原因为COVID-19相关AKI(59.8%),其次为COVID-19相关肺炎(28.7%)和住院(21.3%)。
  • 最常见担忧为捐赠后肾脏健康(59.2%)、传播给受者风险(55.7%)、供者围手术期肺部风险(41.4%)和供者未来肺部风险(29.9%)。

临床怎么用

  • 临床可参考多数中心倾向的至少1个月等待期,但需个体化评估供者COVID-19相关肾损伤和肺部并发症。
  • 对COVID-19康复活体肾供者应关注长期肾脏健康和肺部风险,并进行密切随访。

局限性

  • 调查时间为2020年,可能不能反映当前实践。
  • 应答率为59%的项目和约72%的供者量,存在选择偏倚可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: A critical question facing transplant programs is whether, when, and how to safely accept living kidney donors (LKDs) who have recovered from COVID-19 infection. The purpose of the study is to understand current practices related to accepting these LKDs. METHODS: We surveyed US transplant programs from 3 September through 3 November 2020. Center level and participant level responses were analyzed. RESULTS: A total of 174 respondents from 115 unique centers responded, representing 59% of US LKD programs and 72.4% of 2019 and 72.5% of 2020 LKD volume (Organ Procurement and Transplantation Network-OPTN 2021). In all, 48.6% of responding centers had received inquiries from such LKDs, whereas 44.3% were currently evaluating. A total of 98 donors were in the evaluation phase, whereas 27.8% centers had approved 42 such donors to proceed with donation. A total of 50.8% of participants preferred to wait >3 months, and 91% would wait at least 1 month from onset of infection to LD surgery. The most common reason to exclude LDs was evidence of COVID-19-related AKI (59.8%) even if resolved, followed by COVID-19-related pneumonia (28.7%) and hospitalization (21.3%). The most common concern in accepting such donors was kidney health postdonation (59.2%), followed by risk of transmission to the recipient (55.7%), donor perioperative pulmonary risk (41.4%), and donor pulmonary risk in the future (29.9%). CONCLUSION: Practice patterns for acceptance of COVID-19-recovered LKDs showed considerable variability. Ongoing research and consensus building are needed to guide optimal practices to ensure safety of accepting such donors. Long-term close follow-up of such donors is warranted.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Jan MY, Jawed AT, Barros N, et al. A National Survey of Practice Patterns for Accepting Living Kidney Donors With Prior COVID-19. Kidney Int Rep. 2021. PMID: 34027242. doi:10.1016/j.ekir.2021.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。